Results 141 to 150 of about 6,061,554 (251)

DQ-BSA proteolytic activity assay v1

open access: yes
This protocol measures lysosomal proteolytic activity in human iPSC-derived astrocytes using DQ Red BSA (Thermo D12051). Upon lysosomal proteolysis, DQ-BSA becomes fluorescent, allowing quantification by live-cell imaging or flow cytometry.
Camille Goldman
core   +1 more source

Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair

open access: yesAdvanced Science, EarlyView.
A multifunctional regenerative composite is constructed by 3D‐printing thermosensitive PNIPAM hydrogel embedded with MPDA@IL‐10 nanoparticles and autologous BMSCs onto antigen‐depleted porcine bone matrix for beagle critical‐sized skull defect reconstruction.
Weihao Lv   +16 more
wiley   +1 more source

Degradation graphs reveal hidden proteolytic activity in peptidomes. [PDF]

open access: yesPLoS Comput Biol
Hartman E, Malmström J, Wallin J.
europepmc   +1 more source

Extracellular Vesicles Secreted by Acanthamoeba culbertsoni Have COX and Proteolytic Activity and Induce Hemolysis. [PDF]

open access: yesMicroorganisms, 2023
Sierra-López F   +10 more
europepmc   +1 more source

PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR‐T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy

open access: yesAdvanced Science, EarlyView.
This study shows that a PARP inhibitor combined with anlotinib, administered as bridging therapy, preconditions the tumor microenvironment to enhance the infiltration and antitumor activity of subsequently infused CAR‐T cells across preclinical ovarian cancer models, supporting bridging therapy as a promising strategy to address limited CAR‐T cell ...
Huayi Li   +20 more
wiley   +1 more source

Single-Particle Plasmon Sensor to Monitor Proteolytic Activity in Real Time. [PDF]

open access: yesACS Appl Opt Mater, 2023
Oliveira-Silva R   +5 more
europepmc   +1 more source

A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau

open access: yesAdvanced Science, EarlyView.
TP2 is a fully synthetic small‐molecule dephosphorylation‐targeting chimera that recruits endogenous PP2A‐Bα to Tau, enabling targeted removal of pathological phosphate modifications. In two tauopathy mouse models, systemic TP2 reduces Tau pathology, preserves neuronal and synaptic integrity, improves neuroimmune homeostasis, and rescues cognition ...
Fei Sun   +12 more
wiley   +1 more source

Express Diagnostics of Proteolytic Activity of Periodontopathogens-Methodological Approach. [PDF]

open access: yesDent J (Basel), 2022
Aronova E   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy